1 |
King, R. W., R. J. Deshaies, J. M. Peters and M. W. Kirschner. 1996. How proteolysis drives the cell cycle. Science 274, 1652-1659
DOI
ScienceOn
|
2 |
Hartmann-Petersen, R., M. Seeger and C. Gordon. 2003. Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 28, 26-31
DOI
ScienceOn
|
3 |
Kubbutat, M. H. and K. H. Vousden. 1997. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell. Biol. 17, 460-468
DOI
|
4 |
Mellgren, R. L., Q. Lu, W. Zhang, M. Lakkis, E. Shaw and M. T. Mericle. 1996. Isolation of a Chinese hamster ovary cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate. J. Biol. Chem. 271, 15568-15574
DOI
|
5 |
Walowitz, J. L., M. E. Bradley, S. Chen and T. Lee. 1998. Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J. Biol. Chem. 273, 6656-6661
DOI
ScienceOn
|
6 |
Sato, K. and S. Kawashima. 2001. Calpain function in the modulation of signal transduction molecules. Biol. Chem. 382, 743-751
DOI
|
7 |
Solomon, V. and A. L. Goldberg. 1996. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271, 26690-26697
DOI
ScienceOn
|
8 |
Squier, M. K. and J. J. Cohen. 1997. Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol. 158, 3690-3697
|
9 |
Squier, M. K., A. J. Sehnert, K. S. Sellins, A. M. alkinson, E. Takano and J. J. Cohen. 1999. Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 178, 311-319
DOI
ScienceOn
|
10 |
Suzuki, K. and H. Sorimachi. 1998. A novel aspect of calpain activation. FEBS Lett. 433, 1-4
DOI
ScienceOn
|
11 |
Suzuki, K., S. Hata, Y. Kawabata and H. Sorimachi. 2004. Structure, activation, and biology of calpain. Diabetes 53, S12-18
DOI
ScienceOn
|
12 |
Maki, C. G., J. M. Huibregtse and P. M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654
|
13 |
Hunter, T. and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582
DOI
ScienceOn
|
14 |
Jakobisiak, M., S. Bruno, J. S. Skierski, Z. Darzynkiewicz. 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 88, 3628-3632
|
15 |
Josefsberg, L. B., O. Kaufman, D. Galiani, M. Kovo and N. Dekel. 2001. Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation. Biol. Reprod. 64, 871-878
DOI
ScienceOn
|
16 |
Mellgren, R. L. 1980. Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium. FEBS Lett. 109, 129-133
DOI
ScienceOn
|
17 |
Murachi, T. 1989. Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18, 263-294
|
18 |
Musat, M., V. V. Vax, N. Borboli, M. Gueorguiev, S. Bonner, M. Korbonits and A.B. Grossman. 2004. Cell cycle dysregulation in pituitary oncogenesis. Front. Horm. Res. 32, 34-62
DOI
|
19 |
Ortega, S., M. Malumbres and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 602, 73-87
|
20 |
Patel, Y. M. and M. D. Lane. 1996. Role of calpain in adipocyte differentiation. Proc. Natl. Acad. Sci. USA 96, 1279-1284
|
21 |
Roos-Mattjus, P. and L. Sistonen. 2004. The ubiquitin- proteasome pathway. Ann. Med. 36, 285-295
DOI
ScienceOn
|
22 |
Saido, T. C., H. Sorimachi and K. Suzuki. 1994. Calpain: new perspectives in molecular diversity and physiological- pathological involvement. FASEB J. 8, 814-822
DOI
|
23 |
Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine and J. M. Roberts. 1996. Turnover of cyclin E by the ubiquitin- proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979-1990
DOI
|
24 |
Dynlacht, B. D. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389, 149-152
DOI
ScienceOn
|
25 |
Glotzer, M., A. W. Murray and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132-138
DOI
ScienceOn
|
26 |
Franch, H. A. 2002. Pathways of proteolysis affecting renal cell growth. Curr Opin Nephrol. Hypertens. 2002 11: 445-450
DOI
ScienceOn
|
27 |
Goll, D. E., V. F. Thompson, R. G. Taylor and T. Zalewska. 1992. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays 14, 549-556
DOI
|
28 |
Gonen, H., D. Shkedy, S. Barnoy, N. S. Kosower and A. Ciechanover. 1997. On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett. 406, 17-22
DOI
ScienceOn
|
29 |
Hirai, S., H. Kawasaki, M. Yaniv and K. Suzuki. 1991. Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett. 287, 57-61
DOI
ScienceOn
|
30 |
Mellgren, R. L. 1987. Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB J. 1, 110-115
DOI
|
31 |
Sorimachi, H., T. C. Saido and K. Suzuki. 1994. New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett. 343, 1-5
DOI
ScienceOn
|
32 |
Choi, Y. H., S. J. Lee, P. Nguyen, J. S. Jang, J. Lee, M. L. Wu, E. Takano, M. Maki, P. A. Henkart and T. B. Trepel. 1997. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272, 28479-28484
DOI
ScienceOn
|
33 |
Lee, S. J., M. J. Ha, J. Lee, P. Nguyen, Y. H. Choi, F. Pirnia, W. K. Kang, X. F. Wang, S. J. Kim and J. B. Trepel. 1998. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J. Biol. Chem. 273, 10618-10623
DOI
ScienceOn
|
34 |
Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21
DOI
ScienceOn
|